Dr. William S. Breitbart, MD

Dr. Breitbart practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Breitbart's NPI, 1134190911, was assigned on January 30, 2006. Dr. Breitbart holds New York license 151200.

Dr. Breitbart's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Breitbart's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center, Department of Psychiatry & Behavioral Sciences. Dmand AI also links Dr. Breitbart to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Breitbart practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Breitbart's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Breitbart is licensed in New York.

CMS data shows 363 Medicare services from Dr. Breitbart across 4 procedure codes in 2024, for 75 Medicare patients. Medicare paid $31,055 for them. Every service was in an office.

CMS counts 75 Medicare patients who saw Dr. Breitbart in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have depression, and 75% have high cholesterol. Their average risk score is 2.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Breitbart's median patient age at 68, with 52% women.

In 2024, Dr. Breitbart wrote 1,041 Medicare Part D claims for 82 patients. 92% of them were for generic drugs. CMS names the drug for 881 of them, across 22 drugs with 11 or more claims each, at $27,666 in total drug cost. In 2023, CMS named 994 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 74 out of 100 for Dr. Breitbart for performance year 2024, reported as part of a group. Dr. Breitbart accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Breitbart as offering telehealth.

Dmand AI links 150 papers to Dr. Breitbart, published from 2007 to 2025. 2022 was the busiest year, with 9. The most frequent topics are Palliative Care, Depression and Adaptation, Psychological. Dr. Breitbart has published most often in Palliat Support Care. Dr. Breitbart's most frequent co-authors are Yesne Alici, MD, Andrew Hubbard Miller, MD and Eduardo D. Bruera, MD.

Dmand AI links Dr. Breitbart to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 1 general payment to Dr. Breitbart from 1 drug or device company in 2018. Consulting fees make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $9,540.